AstraZeneca PLC (NASDAQ:AZN)
| 65.98 Delayed Data As of Jan 26 |  -0.64 / -0.96%Today’s Change | 52.65 Today|||52-Week Range 72.12 | -2.68% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 1.3B | 782.0M | 784.0M | 893.0M | |
| Short Term Investment Cash | -112.8M | -1.1B | -1.8B | 1.5B | ||
| Cash & Short Term Investments | 6.9B | 5.9B | 4.6B | 5.7B | ||
| Receivables | Receivables | 6.8B | 4.7B | 5.3B | 5.7B | |
| Inventories | Inventories | 2.1B | 2.3B | 3.0B | 2.9B | |
| Current Assets | Other Current Assets | -- | -- | -- | 1.2B | |
| Current Assets | 15.8B | 13.0B | 12.9B | 15.5B | ||
| Total Assets | Property, Plant and Equipment - Gross | 13.8B | 13.5B | 14.6B | 14.6B | |
| Depreciation | -7.4B | -6.6B | -7.0B | -7.2B | ||
| Intangible Assets | 34.5B | 39.2B | 38.0B | 33.7B | ||
| Other Assets | 35.1B | 39.8B | 38.4B | 33.9B | ||
| Total Assets | 60.1B | 62.5B | 63.4B | 60.7B | ||
| Liabilities | Accounts Payable | 3.5B | 3.0B | 3.6B | 1.7B | |
| Short Term Debt | 916.0M | 2.3B | 2.2B | 1.8B | ||
| Accrued Expenses | 3.0B | 2.9B | 3.6B | 4.9B | ||
| Other Current Liabilities | 9.0B | 8.6B | 9.2B | 11.7B | ||
| Other Liabilities | 14.9B | 15.3B | 16.4B | 16.3B | ||
| Total Liabilities | Long Term Debt | 14.1B | 14.5B | 15.6B | 17.4B | |
| Deferred Taxes | -1.4B | -2.9B | -1.8B | -907.0M | ||
| Other Liabilities | 7.5B | 9.6B | 7.8B | 6.7B | ||
| Total Liabilities | 41.6B | 45.9B | 46.7B | 46.6B | ||
| Equity | Minority Interest | -998.4K | -92.8M | -134.4M | -104.8M | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 18.5B | 14.9B | 15.0B | 12.5B | ||
| Total Shareholder Equity | 18.5B | 14.9B | 15.0B | 12.5B | ||
| Share Information | Common Shares Outstanding | 2.5B | 2.5B | 2.5B | 2.5B | |
| Addtl. Info. | No data currently available for this section. | |||||